Grow Therapy Raises $150 Million to Expand Access to Mental Health Care

Grow Therapy, a leading provider of integrated mental healthcare, has raised $150 million in funding led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from new investors BCI and Menlo Ventures, as well as existing investors Sequoia, SignalFire and Transformation Capital.

Orrick advised Grow Therapy.

THE COMPANY

Grow Therapy connects insurers, employers and health systems to a national network of high-quality, affordable mental health professionals. The company's platform streamlines access and helps address critical gaps in mental healthcare delivery across the United States.

THE IMPACT

The financing marks a significant milestone in Grow Therapy's mission to break down barriers and improve outcomes for individuals seeking mental health support.

This latest investment enables Grow Therapy to further scale its platform, expand partnerships and accelerate development of tools that make mental health care more accessible and effective.

THE TEAM

Orrick's Josh Pollick and George Pothoulakis led the team that advised Grow Therapy. The team also included Serena Tibrewala.

LEARN MORE

• Grow Therapy News Release
• Read More Orrick Client Results